Slide 1: Q4 FY2014 Conference Call
Q4 FY2014 Conference Call July 23, 2014 AngioDynamics, the AngioDynamics logo and other trademarks displayed in this presentation are trademarks owned and used by AngioDynamics, Inc. © Copyright 2014 AngioDynamics, Inc. All rights reserved. *
Slide 2: Forward-Looking Statements
Forward-Looking Statements Notice Regarding Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics’ expected future financial position, results of operations,
Slide 3: Financial Snapshot
Financial Snapshot * -2% -1% 0% 1% 2% 3% 4% 5% 6% 7% Q1 FY13 Q12 FY13 Q3 FY13 Q4 FY13 Q1 FY14 Q12 FY14 Q3 FY14 Q4 FY14 Average Daily Sales (ADS) Growth1,2 FY14 Revenue $354.5M Q4 FY14 Results EPS Sales 1X-BSC excludes the planned wind down of our supply agreement with Boston Scientific. 2Average Dai
Slide 4: Franchise Snapshot
Franchise Snapshot * Quarterly Franchise Growth FY14 Franchise Growth 7% Peripheral Vascular • 0% Vascular Access • 5% Oncology/ Surgery
Slide 5: BioFlo Penetration
BioFlo Penetration FACILITY 1 1,251 BioFlo PICCs placed 85% reduction in symptomatic UEDVT 7 UEDVTs reported from 1251 PICCs UEDVT rate of .45% versus prior 3.1% FACILITY 2 272 BioFlo PICCs placed 42% reduction in Occlusions 19.7% reduction in baseline occlusion rate FACILITY 3 776 BioFlo PICCs plac
Slide 6: Growth Driver – BioFlo Family
wth Driver – BioFlo Family * [ Sales Growth (PICCs, Ports & Dialysis Combined) MILLIONS FY14 BioFlo Family Facts 619 Total Accounts • 135 Additional Under Evaluation Percent Of Total Product Line Sales 46% PICCs • ] 10% Ports • 250 New Accounts
Slide 7: Growth Driver - BioFlo Family
MILUONS Growth Driver - BioFlo Family Sales Growth {PICCs, Ports & DialysisCombined) 46% Pieces Percent 10% Ports aaryad FY14 BioFlo Family Facts 619 Total Accounts 250 New Accounts 135 Additional Under Evaluation i>) angiodynamics
Slide 8: Growth Driver – AngioVac Cannula & Circuit
rowth Driver – AngioVac Cannula & Circuit * Sales Growth MILLIONS FY14 AngioVac Facts 242 Total Accounts • 176 New Customers
Slide 9: Growth Driver – Acculis Microwave System
Growth Driver – Acculis Microwave System * FY14 Capital Facts 202 MW Install Base • 88 MW New Units Sold FY14 Disposable Growth 31% NanoKnife • 82% Microwave O/S Disposable Quarterly Growth Rates Q1 FY14 Q12 FY14 Q3 FY14 Q4 FY14 -8% RF 100 NK Install Base 22 NK New Units Sold
Slide 10: AngioDynamics, the AngioDynamics logo and other trademarks displayed in this presentation are trademarks owned
AngioDynamics, the AngioDynamics logo and other trademarks displayed in this presentation are trademarks owned and used by AngioDynamics, Inc. © Copyright 2012 AngioDynamics, Inc. All rights reserved. *